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Comparison of real-time elastography and multiparametric MRI for prostate
cancer detection: A whole-mount step-section analysis
Abstract
OBJECTIVE. The purpose of this study was to compare prostate cancer detection rate of real-time
elastography (RTE) with that of multiparametric MRI to evaluate the advantages and disadvantages of the
two methods. SUBJECTS AND METHODS. Thirty-nine patients with biopsy-proven prostate cancer
underwent both RTE and multiparametric MRI to localize prostate cancer before radical prostatectomy.
RTE was performed to assess prostate tissue elasticity, and hard lesions were considered suspicious for
prostate cancer. Multiparametric MRI included T2-weighted MRI, diffusion-weighted MRI (DWI), and
contrast-enhanced MRI (CE-MRI) with an endorectal coil at 1.5 T. After radical prostatectomy, wholemount step sections of the prostate were generated, and the prostate cancer detection rates with both
modalities were analyzed for cancer lesions measuring 0.2 cm 3 or larger. RESULTS. Histopathologic
examination revealed 61 cancer lesions. RTE depicted 39 of 50 cancer lesions (78.0%) in the peripheral
zone and 2 of 11 (18.2%) in the transitional zone. Multiparametric MRI depicted 45 of 50 cancer lesions
(90.0%) in the peripheral zone and 8 of 11 (72.7%) in the transitional zone. Significant differences between
the two modalities were found for the transitional zone and anterior part in prostates with volumes
greater than 40 cm3 (p < 0.05). Detection rates for high-risk prostate cancer (Gleason score ≥ 4 and 3)
and cancer lesions with volumes greater than 0.5 cm3 were high for both methods (93.8% and 80.5% for
RTE, 87.5% and 92.7% for multiparametric MRI). Volumetric measurements of prostate cancer were more
reliable with T2-weighted MRI than with RTE (Spearman rank correlation, 0.72 and 0.46). CONCLUSION.
RTE and multiparametric MRI depicted high-risk prostate cancer with high sensitivity. However,
multiparametric MRI seems to have advantages in tumor volume assessment and for the detection of
prostate cancer in the transitional zone and anterior part within prostates larger than 40 cm3. American
Roentgen Ray Society.
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OBJECTIVE. The purpose of this study was to compare prostate cancer detection rate of
real-time elastography (RTE) with that of multiparametric MRI to evaluate the advantages
and disadvantages of the two methods.
SUBJECTS AND METHODS. Thirty-nine patients with biopsy-proven prostate cancer underwent both RTE and multiparametric MRI to localize prostate cancer before radical
prostatectomy. RTE was performed to assess prostate tissue elasticity, and hard lesions were
considered suspicious for prostate cancer. Multiparametric MRI included T2-weighted MRI,
diffusion-weighted MRI (DWI), and contrast-enhanced MRI (CE-MRI) with an endorectal
coil at 1.5 T. After radical prostatectomy, whole-mount step sections of the prostate were generated, and the prostate cancer detection rates with both modalities were analyzed for cancer
lesions measuring 0.2 cm3 or larger.
RESULTS. Histopathologic examination revealed 61 cancer lesions. RTE depicted 39
of 50 cancer lesions (78.0%) in the peripheral zone and 2 of 11 (18.2%) in the transitional
zone. Multiparametric MRI depicted 45 of 50 cancer lesions (90.0%) in the peripheral zone
and 8 of 11 (72.7%) in the transitional zone. Significant differences between the two modalities were found for the transitional zone and anterior part in prostates with volumes greater
than 40 cm3 (p < 0.05). Detection rates for high-risk prostate cancer (Gleason score ≥ 4 and
3) and cancer lesions with volumes greater than 0.5 cm3 were high for both methods (93.8%
and 80.5% for RTE, 87.5% and 92.7% for multiparametric MRI). Volumetric measurements
of prostate cancer were more reliable with T2-weighted MRI than with RTE (Spearman rank
correlation, 0.72 and 0.46).
CONCLUSION. RTE and multiparametric MRI depicted high-risk prostate cancer with
high sensitivity. However, multiparametric MRI seems to have advantages in tumor volume
assessment and for the detection of prostate cancer in the transitional zone and anterior part
within prostates larger than 40 cm3.

O

ne of the key requirements of
prostate imaging is to support
clinicians in managing the diagnosis of and therapy for prostate
cancer. The diagnosis of prostate cancer is
confirmed by histologic examination of systematic biopsy specimens, but the cancer is
not usually visualized with systematic biopsy [1], and therefore prostate cancer may be
missed [2]. Most biopsy specimens are obtained from the posterolateral part of the
prostate; sampling of the anterior regions
and the transitional zone is not recommended, especially in the first systematic biopsy
[1, 3]. Durmus et al. [4] suggest targeted biopsy when multiparametric MRI is performed and novel transrectal ultrasound
technologies rather than systematic biopsy.

Besides being useful for tumor localization,
prostate imaging provides information about
tumor volume, extracapsular extension, seminal vesical invasion, and the degree of cancer aggressiveness. This information may be
helpful for choosing the most appropriate
therapy, especially focal therapy, active surveillance, and watchful waiting [5, 6].
Two imaging modalities have been reported to be reliable for prostate imaging and prostate cancer detection. Real-time elastography
(RTE) is an ultrasound technique that provides information about tissue elasticity and
color codes hard areas, in blue for example
[7]. Prostate cancer has higher cell and vessel density than the normal surrounding tissue
and therefore exhibits increased stiffness [8].
RTE can be performed under real-time condi-
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tions, which is useful for targeted biopsy [9].
Multiparametric MRI has been introduced to
raise the overall diagnostic accuracy in prostate cancer diagnosis by revealing structural
and functional tissue information that may
help identify prostate cancer [10]. In multiparametric MRI conventional T2-weighted
sequences are used to assess structural tissue
information, and at least two functional techniques are added, such as diffusion-weighted
imaging (DWI) to assess water diffusibility
and contrast-enhanced MRI (CE-MRI) to assess contrast dynamics [11].
The aim of this study was to test whether—
depending on tumor localization, clinical significance, or prostate volume—either RTE or
multiparametric MRI is superior for the detection of prostate cancer. Although solid data
from assessments of each modality separately
exist in the literature, in this study we evaluated both modalities in the same cohort of patients. We compared diagnostic performance
and estimation of tumor volume for RTE and
multiparametric MRI in patients with known
prostate cancer using prostate whole-mount
step section as the standard of reference. To
our knowledge, this is only the second study
comparing RTE with multiparametric MRI
and the fourth comparing RTE with MRI in
general [12–14].
Subjects and Methods
Patients
From April 2010 to January 2012, 40 patients
(median age, 62 years; range, 48–75 years) participated in this prospective single-center study.
The median serum prostate-specific antigen concentration was 5.2 ng/mL (range, 2.1–14 ng/mL);
median prostate volume, 31 cm3 (range, 15–130
cm3); and median time between biopsy and imaging, 79 days (range, 40–219 days). A positive
vote of the local ethics committee and written
informed consent were obtained. All men had
biopsy-proven prostate cancer and were scheduled for radical prostatectomy at our institution.
After radical prostatectomy the pathologist prepared the prostates as whole-mount step sections
and marked the borders of all diagnosed cancer
lesions. Thirty-nine of the 40 participants underwent first RTE and then multiparametric MRI the
day before radical prostatectomy. The excluded
patient underwent RTE but not MRI because of a
scheduling conflict. Thirty-eight of the 39 patients
underwent all three MRI techniques: T2-weighted
MRI, DWI, and CE-MRI. Because of feeling uncomfortable during the examination, one patient
underwent only T2-weighted-MRI and DWI but
was not excluded from statistical analysis.

W264

Fig. 1—62-year-old
man with prostate
cancer. Real-time
elastogram shows two
hard lesions (calipers,
blue) in peripheral zone
of prostate. D1, D2 =
diameters of first lesion.
D3 = long diameter of
second lesion.

62-Time Elastography
RTE was performed by an experienced operator using a 7.5-MHz end-firing transrectal probe
and an EUB 8500 ultrasound unit (Hitachi Medical Systems) to assess tissue elasticity. Images were
generated by slight prostate compression and decompression with the transrectal probe. Hard areas were color-coded blue and considered suspicious for prostate cancer (Fig. 1). These areas had
to be reproducible in the axial and sagittal planes
according to a previously described approach, and
the diameters in all three orientations were measured [15]. The operator was blinded to multiparametric MRI, clinical, and histopathologic findings.

Multiparametric MRI
Multiparametric MR images were interpreted by
an experienced reader. MRI was performed with a
1.5-T system (Avanto, Siemens Healthcare) and a
six-channel phased-array body coil combined with
an endorectal coil. After digital rectal examination
the balloon of the endorectal coil was inflated with
50 mL of air. A volume calculation for cancer-suspicious lesions was performed on T2-weighted 3D turbo spin-echo with variable flip angle (SPACE, Siemens Healthcare) images with the volumetric tool
Syngovia (Siemens Healthcare). Each MRI tech-

nique was scored according to how it represented a
suspicious prostate cancer lesion. The summary of
these points (3–9 points) was the final score. Lesions
with more than 5 points were considered to be suspicious for cancer. The reader was blinded to RTE,
clinical, and histopathologic findings.

T2-Weighted MRI
T2-weighted MR images were obtained in the
axial and sagittal planes with turbo spin-echo
sequences. The entire prostate and the seminal vesicles were investigated. The axial plane
was defined by an orientation 90° to the urethra
to be comparable to the histopathologic slices. A
SPACE 3D sequence was also performed in the
coronal plane. The T2-weighted MRI parameters
are shown in Table 1. Low-signal-intensity nodules or ill-defined low-signal-intensity areas in the
normally high-signal-intensity peripheral zone or
low-signal-intensity areas with ill-defined margins in the transitional zone were considered suspicious for prostate cancer [16]. On T2-weighted
MR images the reader assigned a score to the findings using a 3-point scale: 1, benign; 2, intermediate; 3, malignant. All volumetric measurements
were performed on T2-weighted images, which
provide the best anatomic information.

TABLE 1: Parameters for Multiparametric MRI
Parameter

T2 Weighted

Diffusion Weighted

Dynamic Contrast Enhanced

Fast spin-echo

Spin-echo echoplanar imaging

T1-weighted 3D FLASH

TR

3520

2200

2.83

TE

87

74

1.02

Sequence

Flip angle (°)

90

90

9

FOV (mm2)

180 × 180

210 × 210

380 × 285

Matrix

25 × 256

128 × 90

256 × 128

3

3

4

Slice thickness (mm)
b value (s/mm2)
Acquisition time (min:s)

50/400/800
1:54

0:46

9:48 (60×)
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Fig. 2—58-year-old man with prostate cancer (arrow)
in left anterior transitional zone.
A–D, Multiparametric T2-weighted low-signalintensity (A) and low apparent diffusion coefficient
(B) images and washout curve (C) in hyperperfused
area (D) show lesion. ROI = region of interest.
E, Histologic whole-mount step section shows
cancer.

Diffusion-Weighted MRI
DW images were obtained in axial planes with
echoplanar imaging sequences at three b values
(50, 400, and 800 s/mm2). Restriction of diffusion
was quantified by apparent diffusion coefficient
(ADC) value. The DWI parameters are shown
in Table 1. On DW images the reader assigned a
score to imaging findings using a 3-point scale according to ADC value: 1, benign at ADC > 1200;
2, intermediate at ADC 900–1200; 3, malignant at
ADC < 900 [16].

Contrast-Enhanced MRI
Contrast-enhanced MR images were obtained
in axial planes with fast 3D T1-weighted volumetric interpolated breath-hold examination (VIBE)
gradient-echo sequences every 7 seconds for approximately 10 minutes during continuous injection of gadolinium contrast material (gadoterate meglumine, Dotarem, Guerbet; flow rate, 0.1
mL/s). The CE-MRI parameters are shown in Table 1. Perfusion curves were generated with the
Tissue4D program (Siemens Healthcare), which
calculates a pharmacokinetic model derived from
the Tofts model. Pharmacokinetic variables, including Ktrans and Kep, were determined [16]. Ar-
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eas with increased time to peak, increased peak
enhancement, and increased washout rate were
considered suspicious for prostate cancer. Asymmetric hyperperfusion or hyperperfusion within a
focal lesion was considered highly suspicious. On
CE-MR images, the reader assigned a score to imaging findings using a 3-point scale: 1, benign; 2,
intermediate; 3, malignant (Fig. 2).

Histopathologic Preparation, Reporting, and
Correlation With Imaging Findings
After radical prostatectomy and fixation, the
prostatectomy specimens were laminated in
4-mm-thick slices with an orientation of 90° to
the urethra. Pathologic analysis was performed
by an experienced pathologist, who marked all
cancer lesions and reported the Gleason score assigned. A shrinkage factor of 10% was into account for assessment of tumor volumes. The prostate of each patient was divided into peripheral
and transitional zone and into anterior, posterior,
right, and left parts. The border between the anterior and posterior parts was defined as the imaginary line through the widest transverse diameter
of the prostate. Only cancer lesions with a volume
of 0.2 cm3 or more were considered for analysis.

Statistical Analysis and Measurements
For all patients, summary statistics were provided with the appropriate measures of location
and measures of variation. Only areas suspicious
for prostate cancer with a volume of 0.2 cm3 or
greater were considered for statistical analysis.
Detection rates including exact 95% CIs were calculated for multiparametric MRI and RTE. The
Fisher exact test was used for comparison. The
measurements of tumor volumes were compared
between histopathologic slices, RTE, and T2weighted MRI by Spearman rank correlation and
exact 95% CIs. All statistical calculations were
performed with SPSS software (version 18.0, IBM
SPSS), and p < 0.05 was considered statistically
significant. All findings of subgroup analyses with
p > 0.03 (anatomic regions of the prostate, prostate volume, tumor volume, and Gleason score)
were interpreted as very conservative. Multivariate analysis was performed; all combinations considered relevant are listed in Table 2.

Results
Histologic examination of the 39 patients
who underwent prostatectomy revealed 61 cancer lesions with a volume of 0.2 cm3 or great-
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TABLE 2: Prostate Cancer Detection Rates Based on Localization, Tumor Volume, Gleason Score, and Prostate Volume
Parameter

Real-Time Elastography

n

%

CI

n

%

CI

p

61

53

86.9

75.8–94.2

41

67.2

54.0–78.7

0.017

Tumor localization
Anterior

20

17

85.0

62.1–96.8

9

45.0

23.1–68.5

0.019

Posterior

41

36

87.8

73.8–95.9

32

78.0

62.4–89.4

0.379

Transitional zone

11

8

72.7

39.0–94.0

2

18.2

2.3–51.8

0.030

Peripheral zone

50

45

90.0

78.2–96.7

39

78.0

64.0–88.4

0.171

anterior and transitional zone

11

8

72.7

39.0–94.0

2

18.2

2.3–51.8

0.030

anterior and peripheral zone

9

9

100.0

66.3–100

7

77.8

40.0–97.2

0.471

anterior and prostate volume < 40 cm3

12

10

83.3

51.6–97.9

7

58.3

27.7–84.8

0.371

anterior and prostate volume > 40 cm3

8

7

87.5

47.3–99.7

2

25.0

3.2–65.1

0.041

Tumor volume (cm3)
≤ 0.5

20

15

75.0

50.9–91.3

8

40.0

19.1–63.9

0.054

> 0.5

41

38

92.7

80.1–98.4

33

80.5

65.1–91.1

0.194

0.5–1

15

15

100.0

78.2–100

12

80.0

51.9–95.7

0.224

>1

26

23

88.4

69.8–97.6

21

80.8

60.6–93.4

0.703

5–7 (3 + 4)

45

39

86.7

73.2–94.9

26

57.8

42.2–72.3

0.004

7 (4 + 3)

10

8

80.0

44.4–97.5

9

90.0

55.5–99.7

1.000

8–10

6

6

100.0

54.1–100

6

100.0

54.1–100

1.000

< 40

42

38

90.5

77.4–97.3

33

78.6

63.2–89.7

0.227

> 40

19

15

78.9

54.4–93.9

8

42.1

20.3–66.5

0.045

Gleason score

Prostate volume (cm3)

er (median, 0.85 cm3; range, 0.2–11.18 cm3), of
which 50 (82.0%) were localized in the peripheral zone, 11 (18.0%) in the transitional zone,
20 (32.9%) in the anterior part, and 41 (67.2%)
in the posterior part of the prostate. The median Gleason score was 7 (range, 5–10).
Prostate Cancer Detection Rates According to
Localization and Prostate Volume
In total, RTE depicted 41 of 61 cancer lesions (67.2%) with a false-positive rate of
25.5%. Multiparametric MRI depicted 53 of
61 lesions (86.9%) with a false-positive rate
of 13.1% (p = 0.017) (Table 2). The combined approach of RTE and MRI depicted 56
of 61 cancer lesions (91.8%).
When cancer lesions were located in the
posterior parts of the prostate, there was no
significant difference in prostate cancer detection rate between RTE (78.0%) and multiparametric MRI (87.8%) (p = 0.379). A
significant difference in prostate cancer detection rate was found in the anterior parts
with an overall sensitivity of 45.0% for RTE
and 85.0% for multiparametric MRI (p =
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0.019). This difference was mainly caused
by coexistent transitional zone localization
or prostate volumes greater than 40 cm3.
However, no significant difference between
the two imaging modalities was found when
anterior cancers were located in the peripheral zone (p = 0.471) or in prostates with volumes less than 40 cm3 (p = 0.371) (Table 2).
Regarding the peripheral zone only, the pros-

tate cancer detection rates for RTE (78.0%)
and multiparametric MRI (90.0%) did not
differ significantly (p = 0.171).
Prostate Cancer Detection Rates According to
Tumor Volumes
Irrespective of tumor volumes, the two modalities had similar detection rates. No significant differences were found. Within each mo-

100

80
Detection Rate (%)
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Total

MRI

Histologic
Finding (n)

60
40

RTE
MRI

20
0

> 0.2−0.5

> 0.5−1

> 1−2

Tumor Volume (cm3)

>2

Fig. 3—Graph shows
prostate cancer detection
rate according to tumor
volume. RTE = real-time
elastography.
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Comparison of Volumetric Measurements
Overall the median cancer volume was
0.82 cm3 (range, 0.21–11.2 cm3). Spearman
rank correlation with histopathologic results
showed a correlation coefficient of 0.72 (CI,
0.57–0.82) for MRI and 0.46 (CI, 0.24–0.64)

Discussion
In general, imaging of prostate cancer is
limited by tumor volume (size) and grade,
because cancers with a predominant Gleason
pattern of 3 (i.e., Gleason score of 6 with 3 +
3 or of 7 with 3 + 4) are intermixed with normal glands and glands with dilated lumina
(sparse tumors) [7, 17, 18]. Delongchamps et
al. [16] used a similar multiparametric MRI
setting with an endorectal coil at 1.5 T and
for prostate cancers with volumes greater
than 0.2 cm3 reported a sensitivity of 80%
for the peripheral zone and 53% for the transitional zone, which are in concordance with
our results. Furthermore, Yerram et al. [19]
found that the presence of only low-suspicion lesions at multiparametric MRI can almost exclude the presence of high-risk prostate cancer. Delongchamps et al. [20] did not
miss a single case of high-risk prostate cancer in a study of targeted MRI-ultrasound
fusion biopsy. These data suggest that clinically significant disease can be detected with
high confidence with imaging techniques

and that therefore these techniques can be reliable tools for clinicians dealing with prostate cancer diagnosis and therapy. Therefore,
the most important issue of this study was to
compare RTE and multiparametric MRI regarding their accuracy in detection and characterization of clinically significant disease.
Tumor volume is one important factor for
defining significant disease. We found comparably high detection rates for prostate cancers with volumes greater than 0.5 cm3 for
both RTE (80.5%) and multiparametric MRI
(92.7%) (Fig. 4). In accordance with the studies by Sumura et al. [14] and Roethke et al.
[18] dealing with detection rates in relation
to tumor volume, in our study both modalities had increasing accuracy for prostate cancer detection with increasing tumor volume.
Sumura et al., to our knowledge the first study
group to evaluate RTE and MRI in the same
patient population, found superiority for RTE
in the detection of small cancer lesions compared with T2-weighted MRI and CE-MRI
separately. In comparison with their findings,
our results suggest that combining T2-weighted MRI, CE-MRI, and DWI increases sensitivity for the detection of small cancer lesions
in multiparametric MRI. This may explain

A

B

C

E

F

Prostate Cancer Detection According to
Gleason Score
For high-risk prostate cancer (Gleason
score ≥ 4 + 3), RTE had a detection rate of
93.8% and MRI of 87.5% (p = 1.0). A significant difference between modalities was found
for the detection of low-risk prostate cancer
(Gleason score ≤ 3 + 4) with detection rates
of 57.8% for RTE and 86.7% for MRI (p =
0.004). In contrast to that of multiparametric MRI, the detection rate of RTE within the
modality was significantly higher for cancer
lesions with a predominant Gleason pattern ≥
4 than for a pattern ≤ 3 (p = 1.000 for multiparametric MRI, p < 0.012 for RTE).

for RTE. Because the CIs do not cover the
particular correlation coefficient, this difference has to be regarded as significant.
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dality the detection rates for tumor volumes
greater than 0.5 cm3 compared with volumes
of 0.5 cm3 or less differed significantly for
RTE (p < 0.003) but not for multiparametric
MRI (p = 0.100) (Fig. 3 and Table 2).

D

0.9
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0.4
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0
−0.1

0
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Time (min)
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Fig. 4—65-year-old man with prostate cancer.
A–F, Axial real-time elastogram (A), T2 -weighted low-signal intensity (B), and low apparent diffusion coefficient (C) MR images, washout curve (E) in hyperperfused
area (D), and histologic whole-mount step section (F) show clinically significant prostate cancer (arrow) midgland in left peripheral zone. ROI = region of interest.

AJR:202, March 2014

W267

Downloaded from www.ajronline.org by 203.10.91.92 on 03/31/16 from IP address 203.10.91.92. Copyright ARRS. For personal use only; all rights reserved

Junker et al.
our observation that the diagnostic accuracy
of RTE was more dependent on tumor size
than was the accuracy of MRI. This agrees
with our observation that Spearman rank correlation was 0.72 for multiparametric MRI
and only 0.46 for RTE in comparisons of volume measurements of cancer lesions with the
histopathologic findings.
According to our findings, multiparametric MRI seems more reliable for tumor volume assessment. Thus for active surveillance
of suspicious lesions and for follow-up examinations to detect tumor growth, MRI seems
to be more reliable. This is in line with the
findings of Curiel et al. [21], who investigated an ultrasonic elastographic imaging system that may provide a simple and cost-effective solution to monitoring high-intensity
focused ultrasound treatments [21]. They assessed the volume of high-intensity focused
ultrasound lesions in prostates and found that
in general tumor volume was underestimated
with elastography in comparison with MRI.
Regarding tumor histology, in the current study comparably high rates of detection
of high-risk prostate cancer were found for
RTE with (93.8%) and multiparametric MRI
(87.5%). The one case of high-risk prostate
cancer missed with RTE was located in the
transitional zone, and the two cases missed
with multiparametric MRI were not visible
because of artifacts of the endorectal coil. Pelzer et al. [12], who also compared RTE findings with multiparametric MRI findings for
prostate cancer diagnosis, found a reduced
rate of detection of low-risk prostate cancer
for both methods compared with detection of
high-risk prostate cancer. Slightly different
from these findings, in our study population
with low serum prostate-specific serum concentrations, multiparametric MRI was superior to RTE for visualization of low-risk prostate cancer (86.7% for multiparametric MRI
and 57.8% for RTE; p < 0.005). This finding
might have occurred because RTE alone can
provide information about tissue hardness
only. In contrast, multiparametric MRI reveals structural and tissue perfusion information. The usefulness of combining RTE with
contrast-enhanced ultrasound has been found
in previous studies [6, 22].
Like those of Pelzer et al. [12], our results
suggest that multiparametric MRI may have
advantages in the detection of transitional zone
cancers. The sensitivities were 72.7% for multiparametric MRI and 18.2% for RTE (p <
0.05). MRI also seems superior for visualization of anterior cancers located in prostates
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with a volume greater than 40 cm3. These results may be explained by cancer localization
and the technical limits of RTE: All transitional zone cancers were highly anterior, and
when calcifications were simultaneously located in the posterior parts of the transitional
zone, there was no possibility of reaching these
regions for RTE and ultrasound. In general this
is due to hardening artifacts. In addition, investigation of the transitional zone and anterior
parts in prostates with benign prostatic hypertrophy is limited for RTE because of stiffness
artifacts of the inner gland [23]. However, RTE
showed no significant difference in the detection of these tumors compared with multiparametric MRI when anterior cancers were located in prostates with a volume less than 40 cm3
(p = 0.37) or in the peripheral zone only (p =
0.45). This observation was also made for the
dorsal parts of the peripheral zone (p = 0.38)
in comparisons of the two modalities. Moreover, with one exception all transitional zone
cancers were low-risk cancers, and significant
differences in prostate cancer detection between RTE and multiparametric MRI in these
regions existed only for cancer lesions 0.5 cm3
and smaller. These findings suggest that investigation of the inner gland and of anterior
regions of the prostate, although less reliable
than MRI, can be accurately performed with
RTE in prostates with a volume less than 40
cm3 and for detection of high-risk tumors by a
skilled investigator.
Our study had several limitations. We did
not have data about intraobserver and interobserver variability for the two methods. Second, we focused this study on correlation with
histopathologic whole-mount step sections,
and because only patients with confirmed
cancer undergo radical prostatectomy it was
not possible to perform a correlation with
negative results. Third, for the same reason,
we knew that every patient had prostate cancer, which is a bias. Fourth, there was no direct image-to-image registration for the original datasets. Therefore, we are not ultimately
sure whether the identical geographic areas
were compared for volumetric analysis. Fifth,
in some patients the endorectal coil used for
multiparametric MRI caused extinction artifacts in posterior regions of the prostate. Thus
two cancer lesions were missed with multiparametric MRI that may have been detected
without the endorectal coil. Sixth, MRI was
performed in a multiparametric way, whereas
ultrasound was performed with RTE alone. A
prospective comparison between multiparametric MRI and multiparametric ultrasound

(i.e., B-mode, contrast-enhanced ultrasound,
and RTE) would be interesting. The final
three limitations were the modest sample size,
performance of a single evaluation of all individuals (reproducibility is unknown) and single pathologist observer, and the variable time
between biopsy and imaging.
Summarizing our results and considering that in contrast to multiparametric MRI,
RTE is a cost-effective and noninvasive technique that can be performed under real-time
conditions, the integration of the two methods in clinical routine can be achieved as
proposed by Heijmink et al. [24]: Because
RTE has similar good reliability for the diagnosis of high-risk cancer, it seems sufficient for screening purposes and for initial
biopsies, in which RTE-targeted cores can
be obtained in addition to systematic cores.
Several studies have shown that this combined approach may raise the overall sensitivity in prostate cancer diagnosis [9, 25]. If
biopsy results are negative but there is ongoing suspicion of prostate cancer, the limitations of RTE, especially for the detection of
transitional zone tumors and anteriorly located tumors in prostates with benign prostatic
hypertrophy, should be remembered. These
patients then may undergo multiparametric
MRI to achieve the high sensitivity of the
combined approach as found in this study. If
lesions suspicious for being prostate cancer
are found at multiparametric MRI, they can
be biopsied with multiparametric MRI targeting or with cognitive or technical fusion
by means of ultrasound [26–28].
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